Association study of common variations of FBN1 gene and essential hypertension in Han Chinese population

Molecular Biology Reports

Volumn 41, Issue 4, 2014, Pages 2257-2264

  Chen, Jinfeng ^a   Yang, Song ^b   Zhao, Xianghai ^b   Shen, Jiahui ^a   Wang, Hairu ^a   Chen, Yanchun ^b   Ji, Yanni ^b   Wang, Wen ^b   Zhou, Wei ^b   Wang, Xuecai ^b   Tang, Junming ^b   Lu, Xiangfeng ^c   Chen, Shufeng ^c   Wang, Laiyuan ^d   Li, Hongfan ^d   Shen, Chong ^a   Zhao, Yanping ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b YIXING PEOPLE S HOSPITAL   (China)

^c FUWAI HOSPITAL   (China)

^d CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

Author keywords

Association study; FBN1 gene; Hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; BENAZEPRIL; CAPTOPRIL; FIBRILLIN 1; INDAPAMIDE; JIANG YA; METOPROLOL TARTRATE; NIFEDIPINE; RESERPINE; TRANSFORMING GROWTH FACTOR BETA1; TRIAMTERENE; UNCLASSIFIED DRUG; VALSARTAN; ZHEN JU JIANG YA; ACTIN BINDING PROTEIN; FIBRILLIN;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; ESSENTIAL HYPERTENSION; FBN1 GENE; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; AGED; ALLELE; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; BLOOD PRESSURE; CHINA; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; HYPERTENSION; QUANTITATIVE TRAIT; RISK;

AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; CASE-CONTROL STUDIES; CHINA; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HAPLOTYPES; HUMANS; HYPERTENSION; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT, HERITABLE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84897523884     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-014-3078-9     Document Type: Article

References (31)

1. Kannel WB (1993) Hypertension as a risk factor for cardiac events - epidemiologic results of long-term studies. J Cardiovasc Pharmacol 21(Suppl 2):S27-S37
2. Schiffrin EL (2004) Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. Am J Hypertens 17(12 Pt 1):1192-1200 (Pubitemid 40029420)
3. Et-Taouil K, Safar M, Plante GE (2003) Mechanisms and consequences of large artery rigidity. Can J Physiol Pharmacol 81(3):205-211 (Pubitemid 36523644)
4. Laurent S et al (2001) Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37(5):1236-1241 (Pubitemid 34163575)
5. Kingwell BA (2002) Large artery stiffness: implications for exercise capacity and cardiovascular risk. Clin Exp Pharmacol Physiol 29(3):214-217 (Pubitemid 34233978)
6. Kielty CM, Sherratt MJ, Shuttleworth CA (2002) Elastic fibres. J Cell Sci 115(Pt 14):2817-2828
7. Sherratt MJ et al (2001) Fibrillin-rich microfibrils of the extracellular matrix: ultrastructure and assembly. Micron 32(2):185-200
8. Kielty CM et al (2002) Fibrillin-rich microfibrils: elastic biopolymers of the extracellular matrix. J Muscle Res Cell Motil 23(5-6):581-596 (Pubitemid 36583674)
9. Sterzel RB et al (2000) Elastic fiber proteins in the glomerular mesangium in vivo and in cell culture. Kidney Int 58(4):1588-1602
10. Intengan HD et al (1999) Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats: effects of angiotensin receptor antagonism and converting enzyme inhibition. Circulation 100(22):2267-2275
11. Agrotis A, Kalinina N, Bobik A (2005) Transforming growth factor-beta, cell signaling and cardiovascular disorders. Curr Vasc Pharmacol 3(1):55-61 (Pubitemid 40089527)
12. Dietz HC et al (1991) Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352(6333):337-339 (Pubitemid 21912353)
13. Sinha S et al (2002) Expression of latent TGF-beta binding proteins and association with TGF-beta 1 and fibrillin-1 following arterial injury. Cardiovasc Res 53(4):971-983 (Pubitemid 34261035)
14. Ramirez F, Sakai LY (2010) Biogenesis and function of fibrillin assemblies. Cell Tissue Res 339(1):71-82
15. Zhao D et al (2010) Association of the TGF-beta1 gene polymorphisms and blood TGF-beta 1 level with essential hypertension in Kazakh Chinese. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 27(4):463-468
16. Munger JS, Sheppard D (2011) Cross talk among TGF-beta signaling pathways, integrins, and the extracellular matrix. Cold Spring Harb Perspect Biol 3(11):a005017
17. Machado RD et al (2006) Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension. Hum Mutat 27(2):121-132 (Pubitemid 43238027)
18. Shen C et al (2011) Novel genetic variation in exon 28 of FBN1 gene is associated with essential hypertension. Am J Hypertens 24(6):687-693
19. Perloff D et al (1993) Human blood pressure determination by sphygmomanometry. Circulation 88(5 Pt 1):2460-2470
20. Lake SL et al (2003) Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered 55(1):56-65 (Pubitemid 36928747)
21. Davis MR, Summers KM (2012) Structure and function of the mammalian fibrillin gene family: Implications for human connective tissue diseases. Mol Genet Metab 107(4):635-647
22. Robinson PN et al (2002) Mutations of FBN1 and genotype-phenotype correlations in Marfan syndrome and related fibrillinopathies. Hum Mutat 20(3):153-161 (Pubitemid 34966843)
23. Lemaire SA et al (2011) Genome-wide association study identifies a susceptibility locus for thoracic aortic aneurysms and aortic dissections spanning FBN1 at 15q21.1. Nat Genet 43(10):996-1000
24. Carta L et al (2009) Discrete contributions of elastic fiber components to arterial development and mechanical compliance. Arterioscler Thromb Vasc Biol 29(12):2083-2089
25. Saltis J, Agrotis A, Bobik A (1992) TGF-beta 1 potentiates growth factor-stimulated proliferation of vascular smooth muscle cells in genetic hypertension. Am J Physiol 263(2 Pt 1):C420-C428
26. Li B et al (1999) TGF-beta1 DNA polymorphisms, protein levels, and blood pressure. Hypertension 33(1 Pt 2):271-275 (Pubitemid 29065671)
27. Park HC et al (2009) Urinary TGF-beta1 as an indicator of antiproteinuric response to angiotensin II receptor blocker in proteinuric renal diseases. Biomed Pharmacother 63(9):672-678
28. Liu Z, Huang XR, Lan HY (2012) Smad3 mediates ANG II-induced hypertensive kidney disease in mice. Am J Physiol Renal Physiol 302(8):F986-F997
29. August P, Suthanthiran M (2006) Transforming growth factor beta signaling, vascular remodeling, and hypertension. N Engl J Med 354(25):2721-2723
30. Quarto N et al (2012) Exogenous activation of BMP-2 signaling overcomes TGFbeta-mediated inhibition of osteogenesis in Marfan embryonic stem cells and Marfan patient-specific induced pluripotent stem cells. Stem Cells 30(12):2709-2719
31. Wolf G et al (1998) Regulation of glomerular TGF-beta expression in the contralateral kidney of two-kidney, one-clip hypertensive rats. J Am Soc Nephrol 9(5):763-772 (Pubitemid 28209085)